New Insights from Long-Term Clinical Use of Circulating Tumor DNA-Based Minimal Residual Disease Monitoring in Translocation-Associated Sarcomas
Sophie Joch(Medical University of Graz), Markus G. Seidel(Medical University of Graz), Bernadette Liegl‐Atzwanger(Medical University of Graz), Karl Kashofer(Medical University of Graz), Martin Benesch(St Nicholas Hospital), Andrea Thüringer(Medical University of Graz), Amin El‐Heliebi(Medical University of Graz), Andreas Leithner(Medical University of Graz), Joanna Szkandera(Medical University of Graz), Maria Anna Smolle(Medical University of Graz)
Cited by 2
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication
|Brain Behavior and Immunity|2016|741
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2021|558
Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells
|Transfusion|2007|507
Inferring expressed genes by whole-genome sequencing of plasma DNA
|Nature Genetics|2016|463